Burning Rock Biotech (BNR) Competitors $3.30 +0.07 (+2.17%) As of 12:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNR vs. ATPC, SERA, KDLY, QIPT, PIII, OPGN, BDSX, BMGL, CCM, and MRAIShould you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Agape ATP (ATPC), Sera Prognostics (SERA), Kindly MD (KDLY), Quipt Home Medical (QIPT), P3 Health Partners (PIII), OpGen (OPGN), Biodesix (BDSX), Basel Medical Group (BMGL), Concord Medical Services (CCM), and Marpai (MRAI). These companies are all part of the "healthcare" industry. Burning Rock Biotech vs. Agape ATP Sera Prognostics Kindly MD Quipt Home Medical P3 Health Partners OpGen Biodesix Basel Medical Group Concord Medical Services Marpai Agape ATP (NASDAQ:ATPC) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership. Do institutionals & insiders hold more shares of ATPC or BNR? 0.0% of Agape ATP shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 9.7% of Agape ATP shares are owned by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to ATPC or BNR? In the previous week, Burning Rock Biotech's average media sentiment score of 0.00 beat Agape ATP's score of -0.47 indicating that Burning Rock Biotech is being referred to more favorably in the news media. Company Overall Sentiment Agape ATP Neutral Burning Rock Biotech Neutral Which has more risk & volatility, ATPC or BNR? Agape ATP has a beta of -0.55, indicating that its share price is 155% less volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Does the MarketBeat Community prefer ATPC or BNR? Burning Rock Biotech received 5 more outperform votes than Agape ATP when rated by MarketBeat users. Likewise, 31.25% of users gave Burning Rock Biotech an outperform vote while only 0.00% of users gave Agape ATP an outperform vote. CompanyUnderperformOutperformAgape ATPOutperform VotesNo VotesUnderperform Votes1100.00% Burning Rock BiotechOutperform Votes531.25% Underperform Votes1168.75% Is ATPC or BNR more profitable? Burning Rock Biotech has a net margin of -83.50% compared to Agape ATP's net margin of -194.09%. Burning Rock Biotech's return on equity of -60.68% beat Agape ATP's return on equity.Company Net Margins Return on Equity Return on Assets Agape ATP-194.09% -74.71% -56.08% Burning Rock Biotech -83.50%-60.68%-42.30% Which has preferable earnings and valuation, ATPC or BNR? Agape ATP has higher earnings, but lower revenue than Burning Rock Biotech. Agape ATP is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgape ATP$1.29M81.63-$2.10M-$0.60-3.52Burning Rock Biotech$515.82M0.07-$92.07M-$1.88-1.76 SummaryBurning Rock Biotech beats Agape ATP on 11 of the 14 factors compared between the two stocks. Get Burning Rock Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNR vs. The Competition Export to ExcelMetricBurning Rock BiotechMedical laboratories IndustryBusiness SectorNASDAQ ExchangeMarket Cap$35.51M$2.98B$24.20B$8.28BDividend YieldN/A31.23%2.48%4.10%P/E Ratio-1.1013.8032.8619.58Price / Sales0.07157.77271.45119.65Price / CashN/A57.5630.9334.62Price / Book0.314.205.354.47Net Income-$92.07M-$22.21M$195.96M$248.22M7 Day Performance15.79%-2.17%-1.46%-1.32%1 Month Performance12.24%-1.62%15.14%10.73%1 Year Performance-57.14%2.37%18.62%8.40% Burning Rock Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNRBurning Rock Biotech0.4509 of 5 stars$3.30+2.2%N/A-56.2%$35.51M$515.82M-1.101,390Upcoming EarningsGap DownATPCAgape ATP0.4355 of 5 stars$2.03-1.0%N/A-56.6%$101.51M$1.32M-2.7840Analyst UpgradeGap DownSERASera Prognostics1.4844 of 5 stars$2.32+0.4%N/A-77.1%$87.38M$115,000.00-2.34120Positive NewsKDLYKindly MD1.0545 of 5 stars$13.96+7.8%N/AN/A$84.07M$2.47M-18.13N/AGap UpQIPTQuipt Home Medical1.691 of 5 stars$1.40-1.1%$2.85+104.3%-45.5%$60.11M$244.72M-8.21800Analyst DowngradePIIIP3 Health Partners2.1904 of 5 stars$7.94-0.6%$16.25+104.7%-69.7%$57.03M$1.50B-9.45500Gap DownOPGNOpGenN/A$4.89-0.2%N/A+42.3%$49.23M$2.67M0.00100News CoverageAnalyst ForecastBDSXBiodesix3.2758 of 5 stars$0.30-0.1%$2.00+564.5%-76.6%$44.12M$71.32M-0.77220Analyst ForecastHigh Trading VolumeBMGLBasel Medical GroupN/A$2.13-10.1%N/AN/A$39.31M$10.05M0.0036News CoverageCCMConcord Medical ServicesN/A$8.45+0.5%N/A+56.4%$36.69M$383.96M0.00970Gap DownHigh Trading VolumeMRAIMarpaiN/A$1.16-3.9%N/A-33.4%$17.32M$34.87M-0.44150Gap Down Related Companies and Tools Related Companies Agape ATP Competitors Sera Prognostics Competitors Kindly MD Competitors Quipt Home Medical Competitors P3 Health Partners Competitors OpGen Competitors Biodesix Competitors Basel Medical Group Competitors Concord Medical Services Competitors Marpai Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNR) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.